Cargando…
An overview of psoriatic arthritis – epidemiology, clinical features, pathophysiology and novel treatment targets
Psoriatic arthritis is a chronic inflammatory joint disease occurring in a subgroup of patients suffering from psoriasis. This article gives an overview of the complexity of psoriatic arthritis, looking at several aspects of this heterogeneous disease, such as epidemiology, important clinical featur...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Vienna
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5104808/ https://www.ncbi.nlm.nih.gov/pubmed/27822746 http://dx.doi.org/10.1007/s00508-016-1111-9 |
_version_ | 1782466793202253824 |
---|---|
author | Kerschbaumer, Andreas Fenzl, Karl H. Erlacher, Ludwig Aletaha, Daniel |
author_facet | Kerschbaumer, Andreas Fenzl, Karl H. Erlacher, Ludwig Aletaha, Daniel |
author_sort | Kerschbaumer, Andreas |
collection | PubMed |
description | Psoriatic arthritis is a chronic inflammatory joint disease occurring in a subgroup of patients suffering from psoriasis. This article gives an overview of the complexity of psoriatic arthritis, looking at several aspects of this heterogeneous disease, such as epidemiology, important clinical features and comorbidities as well as current concepts of the pathophysiology and subsequent insights in novel treatment targets. |
format | Online Article Text |
id | pubmed-5104808 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Springer Vienna |
record_format | MEDLINE/PubMed |
spelling | pubmed-51048082016-12-06 An overview of psoriatic arthritis – epidemiology, clinical features, pathophysiology and novel treatment targets Kerschbaumer, Andreas Fenzl, Karl H. Erlacher, Ludwig Aletaha, Daniel Wien Klin Wochenschr Review Article Psoriatic arthritis is a chronic inflammatory joint disease occurring in a subgroup of patients suffering from psoriasis. This article gives an overview of the complexity of psoriatic arthritis, looking at several aspects of this heterogeneous disease, such as epidemiology, important clinical features and comorbidities as well as current concepts of the pathophysiology and subsequent insights in novel treatment targets. Springer Vienna 2016-11-07 2016 /pmc/articles/PMC5104808/ /pubmed/27822746 http://dx.doi.org/10.1007/s00508-016-1111-9 Text en © The Author(s) 2016 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Review Article Kerschbaumer, Andreas Fenzl, Karl H. Erlacher, Ludwig Aletaha, Daniel An overview of psoriatic arthritis – epidemiology, clinical features, pathophysiology and novel treatment targets |
title | An overview of psoriatic arthritis – epidemiology, clinical features, pathophysiology and novel treatment targets |
title_full | An overview of psoriatic arthritis – epidemiology, clinical features, pathophysiology and novel treatment targets |
title_fullStr | An overview of psoriatic arthritis – epidemiology, clinical features, pathophysiology and novel treatment targets |
title_full_unstemmed | An overview of psoriatic arthritis – epidemiology, clinical features, pathophysiology and novel treatment targets |
title_short | An overview of psoriatic arthritis – epidemiology, clinical features, pathophysiology and novel treatment targets |
title_sort | overview of psoriatic arthritis – epidemiology, clinical features, pathophysiology and novel treatment targets |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5104808/ https://www.ncbi.nlm.nih.gov/pubmed/27822746 http://dx.doi.org/10.1007/s00508-016-1111-9 |
work_keys_str_mv | AT kerschbaumerandreas anoverviewofpsoriaticarthritisepidemiologyclinicalfeaturespathophysiologyandnoveltreatmenttargets AT fenzlkarlh anoverviewofpsoriaticarthritisepidemiologyclinicalfeaturespathophysiologyandnoveltreatmenttargets AT erlacherludwig anoverviewofpsoriaticarthritisepidemiologyclinicalfeaturespathophysiologyandnoveltreatmenttargets AT aletahadaniel anoverviewofpsoriaticarthritisepidemiologyclinicalfeaturespathophysiologyandnoveltreatmenttargets AT kerschbaumerandreas overviewofpsoriaticarthritisepidemiologyclinicalfeaturespathophysiologyandnoveltreatmenttargets AT fenzlkarlh overviewofpsoriaticarthritisepidemiologyclinicalfeaturespathophysiologyandnoveltreatmenttargets AT erlacherludwig overviewofpsoriaticarthritisepidemiologyclinicalfeaturespathophysiologyandnoveltreatmenttargets AT aletahadaniel overviewofpsoriaticarthritisepidemiologyclinicalfeaturespathophysiologyandnoveltreatmenttargets |